Tag: Covaxin
Biological E. Covid shot Corbevax gets India emergency approval for 12-18 age group
Indian vaccine maker Biological E. Ltd said on Monday its Covid-19 vaccine…
Covid vaccination for 12-14 age group likely from March, says top govt expert
India may begin inoculating children in the 12-14 age group against Covid-19…
How India is Vaccinating Teenagers Amid Omicron Spread
Amid rising Omicron cases, the Centre on Monday rolled out Covid vaccination…
DGCI nod to Covaxin for use in children above 12 years with certain conditions
The Drugs Controller General of India (DCGI) has granted emergency use authorisation…
India, WHO in quid pro quo to resume vaccine exports
India is increasingly at the center of the global debate over how…
Covaxin may get WHO approval by month-end: NITI Aayog
India’s indigenously-developed Covid vaccine Covaxin may soon receive Emergency Use Listing by…
More than 2 billion doses of Covid vaccines to become available in India soon: govt adviser
More than two billion doses of coronavirus vaccines will likely be available…
Only 2 to 4 in 10,000 Indians had breakthrough infection after Covid vaccination
Ahead of further expansion of the COVID inoculation plan to cover all…
0.04 % tested Covid positive after second dose of Covaxin, 0.03% after Covishield: Govt data
More than 21,000 people tested positive for COVID-19 after taking the first…
Govt revises dose interval for Oxford-AstraZeneca’s Covishield vaccine upto 8 weeks
The government on Monday revised the interval between two doses of Oxford-AstraZeneca's Covishield…
Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity: Lancet
India's first indigenous vaccine against COVID-19, Covaxin, showed enhanced immune response without…
8.1 lakh Covaxin doses to be procured from Bharat Biotech for other countries
The Union Health Ministry on Saturday asked the Ministry of External Affairs…
India’s first Covid-19 vaccine: Covaxin Phase-3 trial begins at AIIMS
India-made coronavirus vaccine Covaxin began its phase-three human clinical trial at AIIMS…